Skip to content
WeighLab
Menu
Ranked #83 · Grade C

Andrew Meds review

Andrew Meds publishes $199 semaglutide and $299 tirzepatide on its product pages, then sends every Get Started button to an intake that sells a $99 low-dose program and never offers tirzepatide at all.

Visit Andrew Meds Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199/month month-to-month (the intake this page opens sells a $99 low-dose program instead)
Tirzepatide
$299/month month-to-month
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$2,388

Tirzepatide · modeled / year

$3,588

Pricing verified September 2026

The Index scorecard

Andrew Meds scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month54/100
Price Transparency78/100
Nationwide Access86/100
Formulation Options66/100
Clinical Oversight73/100
Contract Flexibility67/100

Where the value is

  • Full month-to-month and prepay ladders for both molecules are printed on the product pages, before any intake
  • States which pharmacy class fills a prescription — "a 503(A) compounding pharmacy or 503(B) outsourcing facility" — which most sellers at this price leave unsaid
  • Names the prescribing practice, with a street address and a direct phone line, in the footer of every page
  • Splits its coverage honestly: 44 states can be treated from a questionnaire, and seven jurisdictions are named as requiring a live consultation first
  • Free dose increases and treatment changes are stated, so titration does not carry its own charge

The tradeoffs

  • Three live semaglutide prices disagree: $199 a month on the product page, $99 a month in the intake that page links to, and $149 for a four-week supply in a second funnel
  • The tirzepatide page's own funnel offers only semaglutide, so the $299 tirzepatide price cannot be bought through the route the page provides
  • One funnel's ladder does not add up — three months is priced $4 cheaper in total than one month
  • No pharmacy is named, and the terms reserve the right to transfer a prescription between unnamed pharmacies "without notice"
  • The intake promises a money-back weight-loss guarantee that appears nowhere on the marketing site, whose terms say partially used periods are not refunded
  • The District of Columbia is claimed as served and named among the live-visit jurisdictions, but cannot be selected in the intake's state list
  • Efficacy figures shown inside the funnel — an 18% average weight reduction, a 94% chance of success — carry no citation and appear nowhere on the public site

The bottom line

Best for: Shoppers comparing published monthly rates who are willing to check that the price on the page is the price the checkout charges. Andrew Meds publishes $199 semaglutide and $299 tirzepatide on its product pages, then sends every Get Started button to an intake that sells a $99 low-dose program and never offers tirzepatide at all.

Ranked #83 of 529 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 528 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Andrew Meds.

The 21 programs nearest this one

Pricing, states and verification reflect Andrew Meds's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Andrew Meds's site. Not medical advice; see our disclosure.

← Back to the value leaderboard